Nanoparticle drug delivery systems and their use in cardiac tissue therapy

Written by Nanomedicine

In a Review exclusively free for members, Yan Teck Ho et al. from the National University of Singapore examine nanoparticles as drug delivering agents to promote revascularization and therefore help repair damage after for the purposes of treating myocardial infarction. Drugs and growth factors are considered a promising approach for promoting repair after cardiac damage — it has been suggested the positive effects in previous cell transplantation studies have been through paracrine effects rather than integration and differentiation of the transplanted cells. However, in order to avoid cell culture and transplantation, the required factors would need to first be identified,...

To view the full article, please register now for access

It's completely free